McKESSON CORPORATION
At today's price, McKESSON CORPORATION (MCK) is priced for +1.3% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
McKesson compounds earnings steadily off razor-thin distribution margins. Fiscal 2026 adjusted EPS rose 18% to $39.11, and management guided fiscal 2027 to $43.80 to $44.60, another 12% to 14% increase. The price does not require growth to be justified. At $751.42 (as of June 27, 2026) the embedded assumption is essentially flat operating income, supported by earnings-power and peer multiples, which makes the consistent double-digit EPS growth the upside. The governance overhang is the opioid
Is MCK overvalued? See what's priced in →
1,987 institutional managers reported holding MCK in 13F filings for the quarter ended 2026-03-31. Together they hold about 83% of the company; the top 10 hold 39%. 155 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 4.5M shares were sold short as of the 2026-06-15 count, about 4% of shares outstanding (5.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MCK has cut its share count 21.1% over the past five years, spending $17.07B on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting), raised 17 years straight; the current rate is $3.17 a share annually. Cash returned over the past three years: $966.00M in dividends and $10.22B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at MCK over the trailing three years. Absence is a fact about the company, not a signal. 10 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MCK's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-03 | +7.4% | +2.5% |
| 2023-11-03 | -1.7% | +5.6% |
| 2024-02-09 | -2.5% | +4.3% |
| 2024-05-09 | +1.9% | +3.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MCK's latest 8-K filings: 2026-07-01 (items 5.02, 7.01, 9.01); 2026-06-12 (items 1.01, 2.03, 9.01); 2026-05-07 (items 2.02, 9.01); 2026-04-28 (items 1.01, 1.02, 2.03, 9.01); 2026-04-06 (items 1.01, 2.03, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: July 3, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.